IP Library Granted Patent US 9,993,643
Granted Patent B2
US 9,993,643 · App. 14/878,222 · Granted Jun 12, 2018

Electrical stimulation device having multiple stimulation channels

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,993,643
App. No.
14/878,222
Granted
Jun 12, 2018
Kind
B2
Abstract

An implantable electrical stimulation device configured to treat multiple pelvic conditions of a patient includes a pulse generator, memory, first and second electrode leads comprising one or more electrodes, a switch and a controller. The switch has a first state, in which the first electrode lead is electrically coupled to the pulse generator, and a second state, in which the second electrode lead is electrically coupled to the pulse generator. The controller includes at least one processor that is configured to execute at least one stimulation program stored in the memory. The controller is also configured to selectively set the switch in the first or second state. Electrical stimulation pulses generated by the pulse generator responsive to the execution of the stimulation program are delivered to the first or second electrode lead depending on the state of the switch.

Claims (28)

1. An implantable electrical stimulation device for treating multiple pelvic conditions comprising:

an implantable control unit including:

memory;

at least two stimulation programs stored in the memory, the at least two stimulation programs including a first stimulation program and a second stimulation program;

a controller comprising at least one processor configured to execute the at least two stimulation programs stored in the memory;

a first pulse generator circuit configured to generate electrical stimulation pulses in response to execution of the first stimulation program by the controller; and

a second pulse generator circuit configured to generate electrical stimulation pulses in response to execution of the second stimulation program by the controller;

a first electrode lead directly coupled to the first pulse generator circuit, the first electrode lead including one or more electrodes;

a second electrode lead directly coupled to the second pulse generator circuit, the second electrode lead including one or more electrodes, the second electrode lead being a conductive wire physically separate from the first electrode lead,

wherein the electrical stimulation pulses generated by the first pulse generator circuit are delivered to the first electrode lead for treatment of a first pelvic condition,

wherein the electrical stimulation pulses generated by the second pulse generator circuit are delivered to the second electrode lead for treatment of a second pelvic condition.

2. The device of claim 1 , wherein the first pelvic condition is urinary incontinence, and the second pelvic condition is fecal incontinence.

3. The device of claim 1 , wherein the first and second pelvic conditions are selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis, and urine retention.

4. A method of treating multiple pelvic conditions of a patient comprising:

implanting an electrical stimulation device in a patient, the electrical stimulation device including a control unit, memory, a first pulse generator circuit, a second pulse generator circuit, a first electrode lead, and a second electrode lead, the memory storing a first stimulation program and a second stimulation program;

delivering electrical stimulation pulses from the first pulse generator circuit through the first electrode lead in response to executing the first stimulation program using at least one processor of the control unit;

treating a first pelvic condition in response to the delivery of the electrical stimulation pulses through the first electrode lead;

delivering electrical stimulation pulses from the second pulse generator circuit through the second electrode lead in response to executing the second stimulation program using the at least one processor of the control unit;

treating a second pelvic condition in response to the delivery of the electrical stimulation pulses through the second electrode lead.

5. The method of claim 4 , wherein the first pelvic condition is selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis, and urine retention.

6. The method of claim 4 , wherein the second pelvic condition is different than the first pelvic condition.

7. The method of claim 4 , wherein the first and second pelvic conditions are selected from the group consisting of urinary incontinence, fecal incontinence, pain due to interstitial cystitis and urine retention.

8. The method of claim 4 , wherein the implanting the electrical stimulation device in the patient comprises:

implanting one or more electrodes of the first electrode lead at a first stimulation site; and

implanting one or more electrodes of the second electrode lead at a second stimulation site that is different from the first stimulation site.

9. The method of claim 8 , wherein the first and second stimulation sites are selected from the group consisting of a urinary sphincter of the patient and an anal sphincter of the patient.

10. The device of claim 1 , wherein the control unit includes a housing that protects the memory, the at least two stimulation programs, the controller, the first pulse generator circuit, and the second pulse generator circuit when the control unit is implanted within the patient.

11. The device of claim 1 , wherein the first pulse generator circuit and the second pulse generator circuit are separate circuits.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: YONCE, DAVID J.
To: AMS RESEARCH CORPORATION
Reel/Frame 044628/0918 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →